1. Home
  2. VERA vs NHC Comparison

VERA vs NHC Comparison

Compare VERA & NHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • NHC
  • Stock Information
  • Founded
  • VERA 2016
  • NHC 1971
  • Country
  • VERA United States
  • NHC United States
  • Employees
  • VERA N/A
  • NHC N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • NHC Hospital/Nursing Management
  • Sector
  • VERA Health Care
  • NHC Health Care
  • Exchange
  • VERA Nasdaq
  • NHC Nasdaq
  • Market Cap
  • VERA 1.4B
  • NHC 1.6B
  • IPO Year
  • VERA 2021
  • NHC N/A
  • Fundamental
  • Price
  • VERA $24.19
  • NHC $114.71
  • Analyst Decision
  • VERA Buy
  • NHC
  • Analyst Count
  • VERA 8
  • NHC 0
  • Target Price
  • VERA $64.29
  • NHC N/A
  • AVG Volume (30 Days)
  • VERA 1.8M
  • NHC 39.9K
  • Earning Date
  • VERA 08-05-2025
  • NHC 08-08-2025
  • Dividend Yield
  • VERA N/A
  • NHC 2.24%
  • EPS Growth
  • VERA N/A
  • NHC 12.96
  • EPS
  • VERA N/A
  • NHC 6.70
  • Revenue
  • VERA N/A
  • NHC $1,458,155,000.00
  • Revenue This Year
  • VERA N/A
  • NHC N/A
  • Revenue Next Year
  • VERA N/A
  • NHC N/A
  • P/E Ratio
  • VERA N/A
  • NHC $17.19
  • Revenue Growth
  • VERA N/A
  • NHC 24.46
  • 52 Week Low
  • VERA $18.53
  • NHC $89.14
  • 52 Week High
  • VERA $51.61
  • NHC $136.86
  • Technical
  • Relative Strength Index (RSI)
  • VERA 61.33
  • NHC 67.94
  • Support Level
  • VERA $21.71
  • NHC $111.24
  • Resistance Level
  • VERA $23.07
  • NHC $114.00
  • Average True Range (ATR)
  • VERA 1.25
  • NHC 2.15
  • MACD
  • VERA 0.21
  • NHC 0.23
  • Stochastic Oscillator
  • VERA 88.89
  • NHC 92.26

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About NHC National HealthCare Corporation

National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.

Share on Social Networks: